Genworth Financial Authorizes New $350M Share Buyback, Reports $750M Potential Litigation Recovery

summarizeSummary

Genworth Financial announced a new $350M share repurchase program and detailed a potential $750M litigation recovery, alongside a new $500M buyback from its Enact subsidiary, despite a decline in 2025 net income.

check_boxKey Events

• New Share Repurchase Program Authorized

  Genworth Financial's Board of Directors authorized a new share repurchase program on September 18, 2025, allowing for the purchase of up to $350 million of its outstanding common stock. The company repurchased $245 million worth of shares in 2025 and an additional 4,344,376 shares for $8.75 per share between January 1 and February 20, 2026, leaving approximately $222 million available under the program.

• Subsidiary Authorizes $500M Share Buyback

  Enact Holdings, a majority-owned subsidiary, authorized a new $500 million share repurchase program on February 3, 2026. Genworth Financial, as the majority shareholder, expects to receive approximately $405 million in capital returns from Enact Holdings in 2026.

• Potential $750M Litigation Recovery

  A High Court judgment in favor of AXA in the Santander litigation could entitle Genworth to a total recovery of approximately $750 million, with $20 million already received. Any recovery is expected to be deployed towards CareScout investments, share repurchases, and opportunistic debt reduction.

• Decline in 2025 Financial Performance

  Net income available to common stockholders decreased to $223 million in 2025 from $299 million in 2024. Adjusted operating income also declined to $144 million in 2025 from $273 million in 2024, primarily due to lower reserve releases and higher new delinquencies in the Enact segment, and increased losses in the Closed Block segment.

auto_awesomeAnalysis

Genworth Financial's annual report highlights significant capital allocation initiatives and a substantial potential legal recovery, despite a decline in overall net income and adjusted operating income for 2025. The company authorized a new $350 million share repurchase program for its common stock in September 2025, following $245 million in repurchases during 2025. Additionally, its subsidiary, Enact Holdings, authorized a new $500 million share repurchase program in February 2026, from which Genworth expects to receive approximately $405 million in capital returns. A High Court judgment in favor of AXA in the Santander litigation, with a potential recovery of $750 million for Genworth, could further boost liquidity and capital return capacity. While the Closed Block segment continues to face challenges with increased operating losses, the Enact segment remains strong, and the company is investing in new growth initiatives through CareScout. An accounting correction related to reinsurance recoverable measurement, reducing prior equity by $50 million, was noted but deemed immaterial to previously issued financial statements.